Cargando…

Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort

Tobacco cessation among those recently diagnosed with cancer is important to improve their prognosis, yet, many cancer survivors continue to smoke. The epidemiology of tobacco use differs by race and ethnicity, and limited cessation research has been conducted in African American (AA) populations. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Malburg, Carly M., Fucinari, Juliana, Ruterbusch, Julie J., Ledgerwood, David M., Beebe‐Dimmer, Jennifer L., Schwartz, Ann G., Cote, Michele L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571811/
https://www.ncbi.nlm.nih.gov/pubmed/32822118
http://dx.doi.org/10.1002/cam4.3368
_version_ 1783597223277232128
author Malburg, Carly M.
Fucinari, Juliana
Ruterbusch, Julie J.
Ledgerwood, David M.
Beebe‐Dimmer, Jennifer L.
Schwartz, Ann G.
Cote, Michele L.
author_facet Malburg, Carly M.
Fucinari, Juliana
Ruterbusch, Julie J.
Ledgerwood, David M.
Beebe‐Dimmer, Jennifer L.
Schwartz, Ann G.
Cote, Michele L.
author_sort Malburg, Carly M.
collection PubMed
description Tobacco cessation among those recently diagnosed with cancer is important to improve their prognosis, yet, many cancer survivors continue to smoke. The epidemiology of tobacco use differs by race and ethnicity, and limited cessation research has been conducted in African American (AA) populations. Here, we assess demographic and clinical variables associated with continued smoking in AAs after a cancer diagnosis. The Detroit Research on Cancer Survivors study is a cohort comprised of AA cancer survivors with breast, prostate, lung, and colorectal cancers. Detroit Research on Cancer Survivors data were utilized from survivors who completed their baseline survey within 18 months of cancer diagnosis (n = 1145); 18% (n = 356) reported smoking at the time of cancer diagnosis, and 57% of these (n = 203) continued to smoke after their diagnosis. Logistic regression models were used to assess factors associated with continued smoking. Living with a smoker (odds ratio [OR] = 2.78, 95% confidence interval [CI]: 1.64, 4.70), higher cumulative years of smoking (OR = 1.03, 95% CI: 1.01, 1.05, for each year), and a prostate cancer diagnosis (OR = 7.35, 95% CI: 3.89, 13.89) were all associated with increased odds of continued smoking. Survivors with higher social well‐being scores (measured by the Functional Assessment of Cancer Therapy, a quality of life assessment) were more likely to quit smoking after diagnosis (OR = 0.96, 95% CI: 0.93, 1.00). These findings highlight the continued need for personalized cessation strategies to be incorporated into treatment plans for cancer survivors.
format Online
Article
Text
id pubmed-7571811
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75718112020-10-23 Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort Malburg, Carly M. Fucinari, Juliana Ruterbusch, Julie J. Ledgerwood, David M. Beebe‐Dimmer, Jennifer L. Schwartz, Ann G. Cote, Michele L. Cancer Med Cancer Prevention Tobacco cessation among those recently diagnosed with cancer is important to improve their prognosis, yet, many cancer survivors continue to smoke. The epidemiology of tobacco use differs by race and ethnicity, and limited cessation research has been conducted in African American (AA) populations. Here, we assess demographic and clinical variables associated with continued smoking in AAs after a cancer diagnosis. The Detroit Research on Cancer Survivors study is a cohort comprised of AA cancer survivors with breast, prostate, lung, and colorectal cancers. Detroit Research on Cancer Survivors data were utilized from survivors who completed their baseline survey within 18 months of cancer diagnosis (n = 1145); 18% (n = 356) reported smoking at the time of cancer diagnosis, and 57% of these (n = 203) continued to smoke after their diagnosis. Logistic regression models were used to assess factors associated with continued smoking. Living with a smoker (odds ratio [OR] = 2.78, 95% confidence interval [CI]: 1.64, 4.70), higher cumulative years of smoking (OR = 1.03, 95% CI: 1.01, 1.05, for each year), and a prostate cancer diagnosis (OR = 7.35, 95% CI: 3.89, 13.89) were all associated with increased odds of continued smoking. Survivors with higher social well‐being scores (measured by the Functional Assessment of Cancer Therapy, a quality of life assessment) were more likely to quit smoking after diagnosis (OR = 0.96, 95% CI: 0.93, 1.00). These findings highlight the continued need for personalized cessation strategies to be incorporated into treatment plans for cancer survivors. John Wiley and Sons Inc. 2020-08-21 /pmc/articles/PMC7571811/ /pubmed/32822118 http://dx.doi.org/10.1002/cam4.3368 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Malburg, Carly M.
Fucinari, Juliana
Ruterbusch, Julie J.
Ledgerwood, David M.
Beebe‐Dimmer, Jennifer L.
Schwartz, Ann G.
Cote, Michele L.
Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
title Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
title_full Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
title_fullStr Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
title_full_unstemmed Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
title_short Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
title_sort continued smoking in african american cancer survivors: the detroit research on cancer survivors cohort
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571811/
https://www.ncbi.nlm.nih.gov/pubmed/32822118
http://dx.doi.org/10.1002/cam4.3368
work_keys_str_mv AT malburgcarlym continuedsmokinginafricanamericancancersurvivorsthedetroitresearchoncancersurvivorscohort
AT fucinarijuliana continuedsmokinginafricanamericancancersurvivorsthedetroitresearchoncancersurvivorscohort
AT ruterbuschjuliej continuedsmokinginafricanamericancancersurvivorsthedetroitresearchoncancersurvivorscohort
AT ledgerwooddavidm continuedsmokinginafricanamericancancersurvivorsthedetroitresearchoncancersurvivorscohort
AT beebedimmerjenniferl continuedsmokinginafricanamericancancersurvivorsthedetroitresearchoncancersurvivorscohort
AT schwartzanng continuedsmokinginafricanamericancancersurvivorsthedetroitresearchoncancersurvivorscohort
AT cotemichelel continuedsmokinginafricanamericancancersurvivorsthedetroitresearchoncancersurvivorscohort